Printer Friendly

Evaluating Eye Drop Instillation Technique and Its Determinants in Glaucoma Patients.

1. Introduction

Glaucoma is a chronic eye disease causing blindness in millions of people worldwide [1]. Ocular hypotensive eye drops are the most common treatment for lowering the intraocular pressure, which until now is the only proved way to slow the progression of the disease. During lifelong follow-up, a daily, correct administration by the patient is required. However, it is reported nearly half of the patients with glaucoma could not use the eye drops properly [2].

Unlike oral medicines, eye drops require patients to use proper technique for successful medication administration. This requires not only instilling a single drop accurately into the conjunctiva of the eye but also without contacting eye drop container with the ocular surface or adnexa. It is reported more than half of the patients omitted 10% of doses and 15% of patients omitted half doses [3]. Poor eye drop instillation in adherence not only leads to reduced treatment effectiveness but also increases costs in such chronic disease. Systemic side effects, infection, or trauma can also be induced due to overdose or contacting the eye drop container with the eye [4]. Accordingly, this study aimed to explore the status of patients in busy clinical setting of a developing country and to evaluate the determinants of the drop instillation skill.

2. Methods

A cross-sectional design was used and 113 patients with glaucoma were enrolled in this study between August 1,2016 and December 30, 2016. Nine patients who were approached to enroll in the study declined participation. All subjects were consented prior to enrollment and the protocol followed the tenets of the Declaration of Helsinki; the study was approved by the Ethic Board of Zhongshan Ophthalmic Center.

We included all consecutive subjects with diagnosis of glaucoma, aged over 18 years old, self-administrating eye drops with no compliance aids more than 6 months, having better visual acuity no less than 20/200 in either eye, using at least one topical hypotensive medications in one or both eyes. Subjects were only excluded if they had disability in communication or physical impediments to eye drop use [5]. In addition, subjects were required to have had a complete ophthalmic exam within the preceding 6 months. If it was not available, the patient completed testing during study enrollment.

Subject Characteristics--we measured age as continuous variables and gender as a dichotomous variable. Levels of education was originally measured as a categorical variable and then was dichotomized for the multivariable analyses (i.e., under middle school, higher than middle school). The number of glaucoma medications being taken was measured as a continuous variable and then recoded into one versus two or more for the multivariable analyses. Length of time having using antiglaucoma eye drops was measured as a dichotomous variable: one year or more. Visual field defects were classified as mild (mean deviation [greater than or equal to]-6 dB), moderate (mean deviation < -6 but > -12 dB), or severe (mean deviation [less than or equal to]-12 dB) according to Hodapp-Anderson criteria [1]. The reliability parameters of less than 20% errors were used.

Eye drop instillation technique--subjects were first escorted to an exam room and instructed to instill a 5 ml sterile artificial tear solution just as they usually did at home. They were free for a second attempt while they were not satisfied with their first attempt but no prompting was given. The right eye was assigned if the patients had prescribed eye drops for both eyes. The entire process was observed and recorded by two research staff. When there was disagreement between graders, a consensus grading was used. A comprehensive list of items associated with eye drop instillation techniques was developed, based on prior research [6]. Skill score system was based on previous studies [6, 7] which are demonstrated in Table 1. The total process patients instilled eye drops was recorded and scored on each eye drop attempt. Score of quite first drop and last drop, average score of skill of all eye drops, and total skill score were analyzed. Perfect instillation technique was defined as being to instill a single drop in the eye conjunctiva on the first attempt without touching one's eyelid or face. Participants were also asked to recall whether they had had any instruction on skills of instilling eye drops previously, and if so, from whom. Multiple linear regression was examined to explore how the demographic characteristics (gender, age, race, levels of education, number of glaucoma medications, and length of time diagnosed with glaucoma), clinical characteristics, knowledge of using eye drops, and instruction history were associated with total skill score. Next, in a different multivariable logistic regression model, we examined the same factors whether associated with the first drop score system (whether patients had successful perfect eye drop during the first try). Variables with a p <0.05 in the univariable analysis were included in the multivariable regression model.

3. Results

One hundred and thirteen subjects participated in the study and their demographic characteristics are presented in Table 2. Sixty-two of the participates were male, 85% lived in urban and 60% had education level lower than middle school and subjects aged 56.5 years on average. Percentages of subjects with early, mild, and late stage of visual field defect severity for their better eyes were, respectively, 37.2%, 25.7%, and 37.2%. More than half of the sample (54.9%) had been using less than four eye drops and most (95.6%) had a history of less than one year in this study.

As shown in Table 3, most patients (93.8%) controlled the interval between eye drops more than 5 minutes; however, only 3.5% patients knew to press the dacryocyst area after instilling the eye drops. Only a small part of patients (9.7%) have training experience of using eye drops, of which mostly (81.8%) by doctor or nurse in the hospital.

From Table 4, only half (48.67%) of the participants finish administrating eye drops on the first try. The average drops used was 1.7 [+ or -] 0.8 which transformed to 4.35 [+ or -] 0.71 in total score system. The average total skill score was 6.93 [+ or -] 1.88 and first drop skill score was 0.04 [+ or -] 0.47. Of patients regarding quite first drop, 11 (11/113, 9.7%) missed the eye and got contamination with the drop (score of 0), 46 (46/ 113, 40.7%) missed the eye, 7 (7/113, 6.2%) got target but touched the tip of the bottle to the bulbar conjunctiva or cornea, and 24 (24/113, 21.2%) got target but touched the eyelid or lashes with the tip of the bottle. Twenty-five subjects (25/ 113, 22.1%) successfully finished administration during the first try, of which eight subjects (8/113, 7.1%) had the best expertise and scored highest.

Table 5 shows the results of the linear model for predicting good drop instillation technique. Total skill score was chosen as response variable. Factors of demographic, clinical characteristics, knowledge of using eye drops, and previous education were assessed by univariable analysis. It showed that younger age, better education, better visual acuity, knowledge of pressing the dacryocyst area to occlude the punctum, and prior instruction regarding using eye drops were the factors significantly associated with a good technique (p < 0.05 for all). In the multivariable model, only age, visual acuity, and previous education on drop instillation technique remained significant. Table 6 shows the results of the logistic regression model for predicting whether it finished successfully in the first drop. Consistent with the total skill predicting model, same risk factors were confirmed in the univariable analysis. However, only age and visual acuity remained significant in multivariable regression. Prior instructions on using eye drops were not included in the final logistic regression model.

4. Discussion

Glaucoma is a slowly progressive eye disease, and prescribed glaucoma regimen adherence has long been an issue with glaucoma patients [5]. Improper administration of eye drops is often of a variety of unintentional noncompliance and underreported [8]. Unawareness is not only from patients but also from eye care providers especially in busy clinical practices [9]. Approximately 80% of patients instill their own eye drops by themselves and mostly, no delivery aids are adopted [10]. Our study indicates that only 19.7% patients managed to successfully instill eye drops into conjunctiva sac on first attempt.

Although volume of one drop (50 uL) dispensed from bottle far exceeds the capacity of conjunctiva sac (5 uL), our study showed it is not easy for patients to achieve the administration of medication. The mean drops squeezed by each patient per application per eye were 1.57. The mean drops instilled in the conjunctiva were 1.33. Brown et al. [11] found that 21% glaucoma patients administered 2 or more drops in their eyes by themselves. In a similar study, Dietlein et al. [12] reported that only 57% patients managed to instill eye drops in the conjunctival sac and 28.5% of patients closed their eyelids for at least 3 minutes after administration, while only 5.7% occluded the punctum. Even worse, only 3.5% (4/113) patients in our study tried to occlude the punctum after administration. A substantial amount of eye drops was wasted and increased the cost associated with treatment due to the faulty instillation technique. Unable to press the dacryocyst area again increased the bypass outflow of the medicine and systemic absorption. Unwanted adverse effects [13] includes those common side effects such as periocular hyperpigmentation caused by prostaglandin, arrhythmias associated with b-blockers, and infrequent side effects such as airway obstruction, thrombocytopenia, and electrolyte disturbances with carbonic anhydrase inhibitors. Adverse effects may bring frustration to patients, which decreases adherence, lowers the effectiveness, and therefore facilitates the swift of treatment to surgery.

Another issue studied in this study is the potential mechanical contact with ocular surface while instilling the eye drop. Underlying complications may range from infections of ocular surface or trauma such as corneal abrasions [14]. In developing countries, contamination to the bottle may happen due to bad living environment [15]. Dietlein et al. [12] reported that scratching of the eye drop container on the cornea or the conjunctiva was observed in 68% of the study group. Severe visual loss due to corneal ulcers caused by Serratia marcescens, secondary to the use of contaminated eye drop containers has been shown by Templeton et al. [16] in their study. Our study showed 37.7% patients got contamination by contacting with ocular surface or adnexa on their first attempt to instill the drops. It deserves great concern in clinical settings as the underlying devastating complications; also, the eye drops inherence such as instillation technique needs to be evaluated before changing the prescribed regime.

In this study, we investigated the associated determinants of the faulty techniques. Older age, worse visual acuity, and no instruction previously were found risk factor-associated faulty techniques. The patients in the study were aged on average 56.53 (range, 18 to 80), wherein the elderly population constitutes a major share as glaucoma mostly affected. Even though we excluded patients with physical inability for administrating eye drops, still older patients had reduced manual dexterity with age. Poor vision results in the inability of patients to visualize the tip of the bottle and erroneous judgments of the height of the tip of the bottle above the ocular plane. A lack of previous instruction obviously contributes to lack of knowledge about the correct technique, such as press the dacryocyst area and avoid the contamination of the drops. It should be an indispensable part of glaucoma care and further studies are needed to explore its positive effect on the adherence of glaucoma patients [17].

A limitation of this study should be noticed. Firstly, a confounding factor to be considered is that the eagerness of the patient to perform the task accurately when being observed by the study staff may also induce a behavioral modification. Secondly, we did not explore the difference of instillation technique in either eye when patients have prescribed eye drops for both eyes. Thirdly, we only included patients with better visual acuity no less than 20/200 in either eye as those with worse visual acuity may have companions to help. However, there are still a considerable number of patients who instill eye drops by themselves, which needs more attention in further studies. Still and all, our study again confirmed the reality of poor drop technique in glaucoma patients.

Despite the ongoing challenge of poor drug adherence of patients with glaucoma, potential strategies come up day in and day out to counter the issue of poor drop adherence. Smart reminding device, ocular sprays, drug-eluting contact lenses, and other modalities of all sorts are on the way to more patients [18]. Moreover, with the advent of surgical innovations, the minimally invasive surgery may have a much smaller chance of risk. Thus, the patients have more options rather than sticking to eye drops [19].

In conclusion, this study clearly shows that a vast majority of glaucoma patients in China are not correctly instilling eye drops. This can lead to serious consequences on the quality of life of the patients. It also highlights the importance of patient education with regard to eye drop instillation whenever glaucoma topical medications are prescribed and a check on this by the eye care providers during follow-up visits.

https://doi.org/10.1155/2018/1376020

Conflicts of Interest

None of the authors has financial or other conflicts of interest concerning this study.

Authors' Contributions

Xinbo Gao and Qiongman Yang contributed equally to this study and share the first authorship.

Acknowledgments

This work was supported in whole by the Medical Scientific Research Foundation of Guangdong Province, China (A2015370).

References

[1] R. R. A. Bourne, G. A. Stevens, R. A. White et al., "Causes of vision loss worldwide, 1990-2010: a systematic analysis," The Lancet Global Health, vol. 1, no. 6, pp. e339-e349, 2013.

[2] C. O. Okeke, H. A. Quigley, H. D. Jampel et al., "Adherence with topical glaucoma medication monitored electronically: the Travatan Dosing Aid study," Ophthalmology, vol. 116, no. 2, pp. 191-199, 2009.

[3] M. A. Kass, D. W. Meltzer, M. Gordon, D. Cooper, and J. Goldberg, "Compliance with topical pilocarpine treatment," American Journal of Ophthalmology, vol. 101, no. 5, pp. 515-523, 1986.

[4] T. S. Bacon, K. C. Fan, and M. A. Desai, "Electronic medical record and glaucoma medications: connecting the medication reconciliation with adherence," Clinical Ophthalmology, vol. 10, pp. 221-225, 2016.

[5] J. C. Tsai, "A comprehensive perspective on patient adherence to topical glaucoma therapy," Ophthalmology, vol. 116, no. 11, pp. S30-S36, 2009.

[6] A. J. Tatham, U. Sarodia, F. Gatrad, and A. Awan, "Eye drop instillation technique in patients with glaucoma," Eye, vol. 27, no. 11, pp. 1293-1298, 2013.

[7] D. M. Carpenter, R. Sayner, S. J. Blalock et al., "The effect of eye drop technique education in patients with glaucoma," Health Communication, vol. 31, no. 8, pp. 1036-1042, 2016.

[8] R. Gupta, B. Patil, B. M. Shah, S. J. Bali, S. K. Mishra, and T. Dada, "Evaluating eye drop instillation technique in glaucoma patients," Journal of Glaucoma, vol. 21, no. 3, pp. 189192, 2012.

[9] J. C. Tsai, C. A. Mcclure, S. E. Ramos, D. G. Schlundt, and J. W. Pichert, "Compliance barriers in glaucoma: a systematic classification," Journal of Glaucoma, vol. 12, no. 5, pp. 393-398, 2003.

[10] M. A. Kass, E. Hodapp, M. Gordon, A. E. Kolker, and I. Goldberg, "Part I. Patient administration of eyedrops: interview," Annals of Ophthalmology, vol. 14, no. 8, pp. 775-779, 1982.

[11] M. M. Brown, G. C. Brown, and G. L. Spaeth, "Improper topical self-administration of ocular medication among patients with glaucoma," Canadian Journal of Ophthalmology, vol. 19, no. 1, pp. 2-5, 1984.

[12] T. S. Dietlein, J. F. Jordan, C. Luke, A. Schild, S. Dinslage, and G. K. Krieglstein, "Self-application of single-use eyedrop containers in an elderly population: comparisons with standard eyedrop bottle and with younger patients," Acta Ophthalmologica, vol. 86, no. 8, pp. 856-859, 2008.

[13] G. Lazcano-Gomez, M. de los Angeles Ramos-Cadena, M. Torres-Tamayo, A. Hernandez de Oteyza, M. Turati-Acosta, and J. Jimenez-Roman, "Cost of glaucoma treatment in a developing country over a 5-year period," Medicine, vol. 95, no. 47, article e5341, 2016.

[14] B. Sleath, D. M. Carpenter, S. J. Blalock et al., "Applying the resources and supports in self-management framework to examine ophthalmologist-patient communication and glaucoma medication adherence," Health Education Research, vol. 30, no. 5, pp. 693-705, 2015.

[15] O. Geyer, E. J. Bottone, S. M. Podos, R. A. Schumer, and P. A. Asbell, "Microbial contamination of medications used to treat glaucoma," British Journal of Ophthalmology, vol. 79, no. 4, pp. 376-379, 1995.

[16] W. C. Templeton III, R. A. Eiferman, J. W. Snyder, J. C. Melo, and M. J. Raff, "Serratia keratitis transmitted by contaminated eyedroppers," American Journal of Ophthalmology, vol. 93, no. 6, pp. 723-726, 1982.

[17] A. Feng, J. O'Neill, M. Holt, C. Georgiadis, M. M. Wright, and S. R. Montezuma, "Success of patient training in improving proficiency of eyedrop administration among various ophthalmic patient populations," Clinical Ophthalmology, vol. 10, pp. 1505-1511,2016.

[18] M. V. Boland, D. S. Chang, T. Frazier, R. Plyler, J. L. Jefferys, and D. S. Friedman, "Automated telecommunication-based reminders and adherence with once-daily glaucoma medication dosing: the automated dosing reminder study," JAMA Ophthalmology, vol. 132, no. 7, pp. 845-850, 2014.

[19] K. W. Muir and P. P. Lee, "Glaucoma medication adherence: room for improvement in both performance and measurement," Archives of Ophthalmology, vol. 129, no. 2, pp. 243-245, 2011.

Xinbo Gao, Qiongman Yang, Wenmin Huang, Tingting Chen, Chengguo Zuo, Xinyan Li, Wuyou Gao, and Huiming Xiao

State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou 510060, China

Correspondence should be addressed to Huiming Xiao; 1250559136@qq.com

Received 2 December 2017; Accepted 11 March 2018; Published 8 April 2018

Academic Editor: Jesus Pintor
TABLE 1: Scheme used to grade eye drop instillation technique.

Description of technique                                         Score

Good technique, on target, and no contamination                    5
Awkward technique, on target, and no contamination                 4
On target but contaminates by touching the bottle tip to the       3
  lashes or lid
On target but contaminates by touching the bottle tip to           2
  bulbar conjunctiva or cornea *
Not on target, and no contamination                                1
Not on target and contaminates the bottle tip by touching the      0
  eye, eyelid, or lashes

On target: delivered the eye drop to the eye or conjunctiva sac; *
Added risk of trauma to ocular surface.

TABLE 2: Patients' demographic, clinical characteristics (N = 113).

Item                                          Result

Demographic characteristics
Age (y), mean (SD)                         56.53 (14.60)
Male sex, n (%)                             62 (54.87)
Education level, n (%)
  [less than or equal to] middle school     60 (53.10)
  >middle school                            53 (46.90)
Location, n (%)
  Urban                                     85 (75.22)
  Rural                                     28 (24.78)
Clinical characteristics
UCVA, * n (%)
Good ([greater than or equal to] 6/12)      84 (74.34)
    Intermediate (<6/12 and                 10 (8.85)
      [greater than or equal to] 6/18)
  Poor (<6/18)                              19 (16.81)
Visual field stage, ** n (%)
  Early stage                               42 (37.17)
  Medium stage                              29 (25.66)
  Late stage                                42 (37.17)
Number of local eye drops, n (%)
  <4                                        62 (54.87)
  4-6                                       51 (45.13)
Duration of using eye drops (y), n (%)
  <1                                        108 (95.58)
  1-5                                        5 (4.42)

SD: standard deviation; UCVA: uncorrected visual acuity. * Use UCVA
of the eye, which had better visual acuity in this item. ** Use visual
field of the eye, which had better visual acuity in this item.

TABLE 3: Patients' knowledge and education experience of using eye
drops (N =113).

Item                                                 Result
Knowledge of using eye drops
Interval between each eye drops, n (%)
  5 minutes                                         7 (6.19)
  10 minutes                                       105 (92.92)
  30 minutes                                        1 (0.88)
Press dacryocyst area, n (%)
  Yes                                               4 (3.54)
  No                                               109 (96.46)
Education/training experience of using eye drops
Having training of using eye drops, n (%)
  Yes                                               11 (9.73)
  No                                               102 (90.27)
Education method, n (%)
  By doctor/nurse in ZOC                            8 (72.73)
  By doctor/nurse in other hospital                 1 (9.09)
  Reading education brochure                        2 (18.18)
Education time, n (%)
  5 minutes                                         4 (36.36)
  10 minutes                                        5 (45.45)
  30 minutes                                        2 (18.18)

SD: standard deviation; ZOC: Zhongshan Ophthalmic Center.

TABLE 4: Patients' skill of using eye drops.

Item                                                         Result
Skill score system
Score of quite first drop of eye drops (0.5), mean (SD)    0.04 (0.47)
Score of number of last drop (0-5), mean (SD)              4.35 (0.71)
Average score of skill of each eye drops (0-5), mean          2.53
(SD)                                                         (1.15)
Total skill score (0-15), mean (SD)                        6.93 (1.88)
First drop score system
Finish in first drop, n (%)
  Yes                                                      55 (48.67)
  No                                                       58 (51.33)

SD: standard deviation.

TABLE 5: Linear model of potential predictors of patients' skill score
of using eye drops (skill score system) (significant items were
highlighted in bold).

                                              Simple regression

                                           [beta] (95% CI)      p value

Demographic characteristics
Mean of age                             -0.05 (-0.07, -0.03)#   <0.001#
Male sex                                 -0.56 (-1.26, 0.14)     0.118
Education level
  [less than or equal to] middle              Reference
    school
  >middle school                         0.88 (0.19, 1.56)#     0.013#
Location
  Urban                                       Reference
  Rural                                  0.31 (-0.51, 1.13)      0.453
Clinical characteristics
UCVA  *
  Good ([greater than or equal to]            Reference
    6/12)
  Intermediate (<6/12 and [greater       0.50 (-0.71, 1.72)      0.416
    than or equal to] 6/18)
  Poor (<6/18)                          -1.25 (-2.18, -0.33)#   0.008#
Visual field stage **
  Early stage                                 Reference
  Medium stage                           -0.61 (-1.51,0.28)      0.179
  Late stage                             0.22 (-0.59, 1.03)      0.588
Number of local eye drops
  <4                                          Reference
  [greater than or equal to] 4           0.40 (-0.30, 1.11)      0.263
Duration of using eye drops (y)
  <1                                          Reference
  1-5                                     0.70 (-1.01,2.41)      0.421
Knowledge of using eye drops
Interval between each eye drops
  5 minutes                                   Reference
  10 minutes                             -0.78 (-2.23, 0.67)     0.289
  30 minutes                             -3.69 (-7.66, 0.28)     0.068
Press dacryocyst area
  Yes                                    3.70 (1.92, 5.48)#     <0.001#
  No                                          Reference
Education/training experience of
  using eye drops
Having training of using eye drops
  Yes                                    2.54 (1.45, 3.63)#     <0.001#
  No                                          Reference

                                        Multiple regression ([dagger])

                                           [beta] (95% CI)      p value

Demographic characteristics
Mean of age                             -0.03 (-0.05, -0.01)#   0.002#
Male sex
Education level
  [less than or equal to] middle
    school
  >middle school                         0.51 (-0.10, 1.11)      0.100
Location
  Urban
  Rural
Clinical characteristics
UCVA  *
  Good ([greater than or equal to]
    6/12)
  Intermediate (<6/12 and [greater       0.10 (-0.94, 1.15)      0.843
    than or equal to] 6/18)
  Poor (<6/18)                          -1.24 (-2.03, -0.45)#   0.002#
Visual field stage **
  Early stage
  Medium stage
  Late stage
Number of local eye drops
  <4
  [greater than or equal to] 4
Duration of using eye drops (y)
  <1
  1-5
Knowledge of using eye drops
Interval between each eye drops
  5 minutes
  10 minutes
  30 minutes
Press dacryocyst area
  Yes                                    1.64 (-0.12, 3.40)      0.068
  No
Education/training experience of
  using eye drops
Having training of using eye drops
  Yes                                    1.71 (0.62, 2.80)#     0.002#
  No

SD: standard deviation; UCVA: uncorrected visual acuity. * Use patient
better-seeing eye's UCVA in this item. **Use patient better-seeing
eye's visual field in this item. ([dagger]) All variables in the
simple regression with p < 0.05 were included in multiple regression.

Note: Significant items are indicated with #.

TABLE 6: Logistic model of potential predictors of patients' skill
score of using eye drops (first drop score system) (significant items
were (significant items were highlighted in bold).

                                            Simple regression

                                         [beta] (95% CI)       p value

Demographic characteristics
Mean of age                           -0.01 (-0.02, -0.004)#   0.002#
Male sex                                0.14 (-0.05, 3.24)      0.151
Education level
  [less than or equal to] middle            Reference
    school
  > middle school                       0.15 (-0.04, 0.34)      0.115
Location
  Urban                                     Reference
  Rural                                 0.07 (-0.15, 0.28)
Clinical characteristics
UCVA *
  Good ([greater than or equal to]          Reference
    6/18)
  Intermediate                          0.52(-0.27, 0.37)       0.747
  Poor (<6/18)                        -0.39 (-0.63, -0.15)#    0.002#
Visual field stage **
  Early stage                               Reference
  Medium stage                         -0.17 (-0.41, 0.07)      0.168
  Late stage                           -0.05 (-0.26, 0.17)      0.665
Number of local eye drops
  <4                                        Reference
  [greater than or equal to] 4          0.08 (-0.11,0.27)       0.415
Duration of using eye drops (y)
  <1                                        Reference
  1-5                                  -0.09 (-0.55, 0.37)      0.695
Knowledge of using eye drops
Interval between each eye drops
  5 minutes                                 Reference
  10 minutes                            0.07 (-0.32, 0.46)      0.735
  30 minutes                            -0.43(-1.50, 0.64)      0.428
Press dacryocyst area
  Yes                                   0.53 (0.03, 1.04)#     0.037#
  No                                        Reference
Education/training experience of
  using eye drops
Having training of using eye drops
  Yes                                   0.37 (0.06, 0.68)#     0.020#
  No                                        Reference

                                      Multiple regression ([dagger])

                                         [beta] (95% CI)      p value

Demographic characteristics
Mean of age                           -0.01 (-0.01, -0.002)#  0.010#
Male sex
Education level
  [less than or equal to] middle
    school
  > middle school
Location
  Urban
  Rural
Clinical characteristics
UCVA *
  Good ([greater than or equal to]
    6/18)
  Intermediate                         -0.01 (-0.32, 0.30)     0.962
  Poor (<6/18)                        -0.38 (-0.61, -0.14)#   0.002#
Visual field stage **
  Early stage
  Medium stage
  Late stage
Number of local eye drops
  <4
  [greater than or equal to] 4
Duration of using eye drops (y)
  <1
  1-5
Knowledge of using eye drops
Interval between each eye drops
  5 minutes
  10 minutes
  30 minutes
Press dacryocyst area
  Yes                                  0.16 (-0.36, 0.68)      0.542
  No
Education/training experience of
  using eye drops
Having training of using eye drops
  Yes                                  0.26 (-0.06, 0.58)      0.109
  No

SD: standard deviation; UCVA: uncorrected visual acuity. * Use patient
better-seeing eye's UCVA in this item. ** Use patient better-seeing
eye's visual field in this item. ([dagger]) All variables in the
simple regression with p < 0.05 were included in multiple regression.

Note: Significant items are indicated with #.
COPYRIGHT 2018 Hindawi Limited
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2018 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Research Article
Author:Gao, Xinbo; Yang, Qiongman; Huang, Wenmin; Chen, Tingting; Zuo, Chengguo; Li, Xinyan; Gao, Wuyou; Xi
Publication:Journal of Ophthalmology
Date:Jan 1, 2018
Words:4394
Previous Article:Mapping the Structure-Function Relationship in Glaucoma and Healthy Patients Measured with Spectralis OCT and Humphrey Perimetry.
Next Article:Risk Factors for Endothelial Decompensation after Penetrating Keratoplasty and Its Novel Therapeutic Strategies.
Topics:

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters